- $168.57m
- $48.99m
- $348.67m
Annual cashflow statement for Inogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.33 | -83.8 | -102 | -35.9 | -22.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 14 | 67.4 | 67 | 26.3 | 18.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -20.1 | -44.7 | 14.3 | -4.39 | -26.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 23.6 | -37.5 | -3.23 | 5.91 | -11.2 |
| Capital Expenditures | -24.1 | -21.2 | -27 | -17.1 | -10.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 9.42 | 10.3 | -32.3 | 3.12 | -15.8 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -14.6 | -10.9 | -59.3 | -14 | -26.2 |
| Financing Cash Flow Items | 1.3 | 0.336 | 0.576 | 0.265 | -3.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 15 | 0.38 | 0.96 | 0.265 | 24.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.6 | -48.5 | -61.5 | -8.08 | -12.4 |